Highlights

• Access to NAD⁺ injection therapy through telehealth
• Ongoing provider messaging and support
• Subscription-based plans with flexible durations
• Medication shipped directly to patients
• Pharmacy quality checks and testing standards

Pros and Cons

Pros

• Strong emphasis on ongoing provider access and support
• Fully online process from consultation to delivery
• Subscription plans with pricing tiers based on commitment length
• Medication prepared through licensed pharmacies with quality checks
• Structured program designed for ongoing use

Cons

• Focused primarily on injectable NAD⁺ formats
• Costs increase without longer-term subscription plans

What is bmiMD NAD⁺

bmiMD offers NAD⁺ therapy through a telehealth platform, focusing on anti-aging and cellular health support.

NAD⁺ is a coenzyme involved in energy production and cellular repair, with levels that tend to decline over time. The platform provides access to compounded NAD⁺ injections, prescribed and monitored by licensed providers.

Treatment is designed as an ongoing program, with continued access to providers and adjustments based on user response rather than a fixed, one-time protocol.

Features & Core Functionality

1. NAD⁺ Injection Therapy
   bmiMD focuses primarily on injectable NAD⁺ treatment, which is delivered through a structured dosing schedule as part of the program.
2. Continuous Provider Access
   One of the platform’s core features is ongoing messaging with providers, allowing users to ask questions and adjust treatment as needed.
3. Telehealth-Based Care
   All consultations, prescriptions, and follow-ups are handled online, removing the need for in-person visits.
4. Pharmacy Quality Testing
   Medications are prepared through licensed pharmacies and undergo testing for potency, sterility, and safety standards before being shipped.
5. Subscription-Based Delivery
   Treatment is structured around monthly or multi-month plans, with automatic refills and delivery built into the program.

Pricing

Pricing varies depending on plan length, with subscription options ranging from monthly to longer-term commitments. Monthly costs can decrease with longer plans, starting higher for short-term access and dropping with extended subscriptions.

Compared to in-clinic NAD⁺ treatments, the at-home model may offer a more accessible entry point, though it still requires ongoing commitment.

The value is tied to the combination of treatment and continuous provider access rather than just the medication

The Bottom Line

bmiMD takes a more continuity-focused approach to NAD⁺ therapy, where the emphasis is less on the initial prescription and more on staying connected throughout treatment. That ongoing support can make a difference for users who want regular input and adjustments, rather than managing everything on their own. At the same time, it shifts the experience toward a longer-term commitment rather than something you can try once and move on from.

For users who value consistent access to providers and a structured routine, bmiMD offers a steady approach to NAD⁺ therapy—just with the expectation that you’ll stay engaged over time.